Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Hepatitis Monthly
  4. Articles

  5. Safety and Efficacy of Adding Ribavirin to Interferon or Peginterferon in Treatment of Hepatitis C Infection in Patients With Thalassemia: A Systematic Review on Randomized Controlled Trials
  6. Scopus by Title (Ref)

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Home
Current IssueAccepted ManuscriptsAll IssuesIn Press ArticlesSearch
Instructions
Journal InformationBoards and committeesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Real-World Experience, Effectiveness, and Safety of Direct-Acting Antivirals for the Treatment of Hepatitis C in Oman: A Cross-Sectional, Multicenter Study

- Al-Naamani K.M. , et al.

2. Biopharmaceutical Production by Recombinant DNA Technology: Future Perspectives

- Parasuraman S. , et al.

3. Hepatoprotective effects of metformin in hepatitis C virus-infected adolescents with beta thalassaemia major

- Talebi A. , et al.

4. HCV Infection in Thalassemia Syndromes and Hemoglobinopathies: New Perspectives

- Maffei L. , et al.

5. Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment

- Alothaid H. , et al.

6. Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis

- Yang C.F. , et al.

7. The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C

- Liang P.C. , et al.

8. Generic Direct Acting Antivirals in Treatment of Chronic Hepatitis C Infection in Patients of Thalassemia Major

- Nagral A. , et al.

9. Treatment of chronic hepatitis c in thalassemia major patients

- Sajjad S.F. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • Accepted Manuscripts
  • All Issues
  • In Press Articles
  • Search

About Journal

  • Journal Information
  • Boards and committees
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.